Bar chart showing non-Hodgkin lymphoma mortality rates from 1982 to 2008. Beginning in 1982, there were between 6 and 7 deaths per 100,000 people from non-Hodgkin lymphoma. The trend increases each year to peak at just fewer than 9 deaths per 100,000 in 1997, when rituximab was approved. Mortality rates have since fallen.